News Archives - QualityStocks

MondayApr 06, 2026 11:15 am

American Fusion(TM) Inc. (AMFN) Expands Industry Engagement, Appoints New CFO to Strengthen Capital Markets Strategy

American Fusion(TM) Inc. is increasing its presence at technical and energy-infrastructure conferences as it advances its fusion development strategy. Company representatives attended both the Applied Power Electronics Conference and the International Workshop on Anomalies in Hydrogen Loaded Metals. The company’s subsidiary, Kepler Fusion Technologies, is developing the unique Texatron(TM) fusion system designed for modular power generation. The company recently appointed Michael Carlson as Chief Financial Officer to guide capital markets strategy and financial operations. The firm is exploring “behind-the-meter” energy deployment strategies to simplify early commercialization. American Fusion (OTC: AMFN), an advanced energy platform company focused on the development and…

MondayApr 06, 2026 10:30 am

Lahontan Gold Corp. (TSX.V: LG) (OTCQB: LGCXF) Strengthens Position in Growing Global Gold Cycle

Disseminated on behalf of  Lahontan Gold Corp. (TSX.V: LG) (OTCQB: LGCXF) and may include paid advertising. World Gold Council research notes that the addition of gold can materially improve a portfolio’s risk-adjusted returns. Lahontan’s potential appeal is its ability to offer investors exposure not just to the gold price but to an advancing Nevada development story in one of the world’s most established mining belts. Recent company activity suggests Lahontan is continuing to advance its development strategy at Santa Fe. Gold’s latest pullback has done little to weaken the deeper investment case for the yellow metal. As recent commentary observes, gold’s…

MondayApr 06, 2026 9:45 am

Safe Pro Group Inc. (NASDAQ: SPAI) Adds Brian Mack to the Company’s Strategic Advisory Board

Safe Pro Group recently announced that the company is adding Brian Mack, a Retired U.S. Army Officer of Acquisition, Contracting & Modernization, to the company’s strategic advisory board. Mack is a former Anduril Senior Business Development Director, and brings with him a proven track record in defense capture, growth strategy, and Army modernization. He joins at a time when Safe Pro Group is looking to accelerate revenue growth, following the company’s recent $1 million U.S. Government subcontract award for its AI-powered edge processing solution. Safe Pro Group (NASDAQ: SPAI), a company that develops security, defense, and situational awareness solutions, recently…

MondayApr 06, 2026 9:00 am

MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF) Targets South American Mining Sector as Voice-Based Drug and Alcohol Impairment Screening Platform Moves Toward Commercial Deployment

Disseminated on behalf of MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF)and may include paid advertising. The company has appointed Chilean drug policy specialist Felipe Leyton to lead commercialization in South America’s mining industry. The company is preparing to deploy its voice-based AI drug and alcohol impairment detection platform in industrial environments beginning in 2026, with Chile’s mining sector, employing more than 200,000 workers, representing an early target market. MindBio’s technology analyzes voice patterns to detect intoxication or impairment without biological testing, and management is positioning the platform as a scalable tool for workplace safety in mining and other high-risk industries.…

ThursdayApr 02, 2026 9:45 am

Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) Strengthens Position amid Global REE Supply Challenges

Disseminated on behalf of Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) and may include paid advertising. Industry analysts project that REEs used in clean-energy technologies could see demand increase two to three times by 2040. Despite the importance of these precious elements, global supply chains for REEs remain highly concentrated. Ucore is developing technologies and facilities designed to process rare earth concentrates into high-purity oxides that can be used in manufacturing. Rare earth elements have become one of the most strategically important groups of materials in the modern global economy, underpinning technologies that range from electric vehicles to advanced…

ThursdayApr 02, 2026 9:00 am

Nevada Organic Phosphate Inc. (CSE: NOP) (OTCQB: NOPFF) Targets Supply Gap in Fertilizer for Expanding Organic Food Market

Disseminated on behalf of Nevada Organic Phosphate Inc. (CSE: NOP) (OTCQB: NOPFF) and may include paid advertising. The organic agriculture sector continues to expand, creating demand for certified inputs that conventional chemical fertilizers cannot provide. Organic Phosphate is developing its Murdock Mountain project in northeastern Nevada to supply organic rock phosphate fertilizer to U.S. farmers, centered on direct-ship rock phosphate that requires minimal processing beyond grinding and bagging. Early drilling at the Murdock Mountain target zone has confirmed phosphate grades and low heavy-metal concentrations compatible with organic farming requirements, and the company has identified multiple phosphate target zones that could…

WednesdayApr 01, 2026 11:15 am

Soligenix Inc. (NASDAQ: SNGX) Advances Clinical Credibility with HyBryte Research Publication

Publishing research in peer-reviewed journals plays a central role in ensuring the credibility and reliability of scientific findings. Companies that consistently publish their findings often strengthen their credibility with both regulators and the medical community. Most recently, SNGX announced that a clinical summary of its HyBryte(TM) therapy for cutaneous T-cell lymphoma was published in the peer-reviewed journal “Expert Opinion on Investigational Drugs.” The publication of clinical research in peer-reviewed journals remains a critical milestone in drug development, offering independent validation and broader visibility for emerging therapies. Soligenix (NASDAQ: SNGX) recently reached such a milestone with the publication of a clinical…

WednesdayApr 01, 2026 10:30 am

Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) Expands Strategy for Critical Magnet Materials Supply

Disseminated on behalf of Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) and may include paid advertising. Recent analysis underscores the vulnerability of specialized rare earth elements samarium and gadolinium. This elevated risk profile is largely driven by the dominance of a single country in rare earth production and processing as well as increasing demand for the elements. Ucore is working to accelerate the commercial development of its planned processing capabilities for these materials. Securing reliable supplies of specialized rare earth elements is becoming increasingly important as demand rises across defense, energy and advanced manufacturing sectors. With this in mind,…

WednesdayApr 01, 2026 9:00 am

Beeline Holdings Inc. (NASDAQ: BLNE) Reports 127% Revenue Growth and Key Milestones Achieved in Q4 2025, Detailing Strategic Priorities for 2026

Beeline Holdings Inc., in a recent update call, reported 127% year-over-year revenue growth for Q4 2025, reflecting the expansion of its digital mortgage platform. Mortgage origination volume rose 44% to $84.7 million during the quarter, and average revenue per loan increased 31%, while cost per loan declined 18%, indicating improving unit economics. Q4 also had the company releasing BeelineEquity, a blockchain-recorded platform allowing homeowners an efficient way to access equity without refinancing. Management says the company ended 2025 debt-free, strengthening its balance sheet ahead of expansion, and executives expect accelerating revenue growth in 2026 as new products and AI-driven automation…

TuesdayMar 31, 2026 11:15 am

LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT) Has the World’s Only Clinical-Stage PP2A Inhibitor, Poised to Improve Cancer Treatment Outcomes

LIXTE’s lead compound, LB-100, is the world’s first and only clinical-stage inhibitor of protein phosphatase 2A (“PP2A”). LB-100 helps in the fight against cancer in a few ways, as it makes cancer cells more sensitive to immunotherapy and chemotherapy, while also disrupting cancer’s internal repair system. The compound has demonstrated a favorable safety profile in Phase 1 clinical trials and has been supported by over 25 published preclinical and translational studies so far. LIXTE Biotechnology Holdings (NASDAQ: LIXT), a clinical-stage pharmaceutical company, is in the unique position of holding the world’s only clinical-stage protein phosphatase 2A (“PP2A”) inhibitor, called LB-100.…

Site Search

Company Search

Category: News